Br xe4 uer S, Rossi M, Sajapin J, Henle T, Gasser T, Parchi P, et al. Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disorders. Acta Neuropathol Commun. 2023;11:162 pubmed publisher

Tahirbegi B, Magness A, Piersimoni M, Teng X, Hooper J, Guo Y, et al. Toward high-throughput oligomer detection and classification for early-stage aggregation of amyloidogenic protein. Front Chem. 2022;10:967882 pubmed publisher

Pieger K, Schmitt V, Gauer C, Gie xdf l N, Prots I, Winner B, et al. Translocation of Distinct Alpha Synuclein Species from the Nucleus to Neuronal Processes during Neuronal Differentiation. Biomolecules. 2022;12: pubmed publisher

Kluge A, Bunk J, Schaeffer E, Drobny A, Xiang W, Knacke H, et al. Detection of neuron-derived pathological α-synuclein in blood. Brain. 2022;: pubmed publisher

Sanders H, Kostelic M, Zak C, Marty M. Lipids and EGCG Affect α-Synuclein Association and Disruption of Nanodiscs. Biochemistry. 2022;61:1014-1021 pubmed publisher

Lau D, Magnan C, Hill K, COOPER A, Gambin Y, Sierecki E. Single Molecule Fingerprinting Reveals Different Amplification Properties of α-Synuclein Oligomers and Preformed Fibrils in Seeding Assay. ACS Chem Neurosci. 2022;13:883-896 pubmed publisher

Ardah M, Eid N, Kitada T, Haque M. Ellagic Acid Prevents α-Synuclein Aggregation and Protects SH-SY5Y Cells from Aggregated α-Synuclein-Induced Toxicity via Suppression of Apoptosis and Activation of Autophagy. Int J Mol Sci. 2021;22: pubmed publisher

Jos S, Gogoi H, Prasad T, Hurakadli M, Kamariah N, Padmanabhan B, et al. Molecular insights into α-synuclein interaction with individual human core histones, linker histone, and dsDNA. Protein Sci. 2021;30:2121-2131 pubmed publisher

Kumar S, Kumar R, Kumari M, Kumari R, Saha S, Bhavesh N, et al. Ellagic Acid Inhibits α-Synuclein Aggregation at Multiple Stages and Reduces Its Cytotoxicity. ACS Chem Neurosci. 2021;12:1919-1930 pubmed publisher

Trinkaus V, Riera Tur I, Martinez Sanchez A, Bäuerlein F, Guo Q, Arzberger T, et al. In situ architecture of neuronal α-Synuclein inclusions. Nat Commun. 2021;12:2110 pubmed publisher

Sharma R, Srivastava T, Pandey A, Mishra T, Gupta B, Reddy S, et al. Identification of Natural Products as Potential Pharmacological Chaperones for Protein Misfolding Diseases. ChemMedChem. 2021;16:2146-2156 pubmed publisher

Luchinat E, Barbieri L, Cremonini M, Banci L. Protein in-cell NMR spectroscopy at 1.2 GHz. J Biomol NMR. 2021;75:97-107 pubmed publisher

Merghani M, Ardah M, Al Shamsi M, Kitada T, Haque M. Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein. Neurotoxicology. 2021;: pubmed publisher

Hou S, Exell J, Welsher K. Real-time 3D single molecule tracking. Nat Commun. 2020;11:3607 pubmed publisher

Lin X, Galaqin N, Tainaka R, Shimamori K, Kuragano M, Noguchi T, et al. Real-Time 3D Imaging and Inhibition Analysis of Various Amyloid Aggregations Using Quantum Dots. Int J Mol Sci. 2020;21: pubmed publisher

Kumar R, Kumar S, Hanpude P, Singh A, Johari T, Majumder S, et al. Partially oxidized DJ-1 inhibits α-synuclein nucleation and remodels mature α-synuclein fibrils in vitro. Commun Biol. 2019;2:395 pubmed publisher

Shirasaka M, Kuwata K, Honda R. α-Synuclein chaperone suppresses nucleation and amyloidogenesis of prion protein. Biochem Biophys Res Commun. 2020;521:259-264 pubmed publisher

Sanyal A, Dutta S, Camara A, Chandran A, Koller A, Watson B, et al. Alpha-Synuclein Is a Target of Fic-Mediated Adenylylation/AMPylation: Possible Implications for Parkinson's Disease. J Mol Biol. 2019;431:2266-2282 pubmed publisher

Wördehoff M, Hoyer W. α-Synuclein Aggregation Monitored by Thioflavin T Fluorescence Assay. Bio Protoc. 2018;8: pubmed publisher

Oliveira Souza W, Bronze F, Broos J, Marcondes M, Oliveira V. On the efficient bio-incorporation of 5-hydroxy-tryptophan in recombinant proteins expressed in Escherichia coli with T7 RNA polymerase-based vectors. Biochem Biophys Res Commun. 2017;492:343-348 pubmed publisher

Kumar S, Jangir D, Kumar R, Kumari M, Bhavesh N, Maiti T. Role of Sporadic Parkinson Disease Associated Mutations A18T and A29S in Enhanced ?-Synuclein Fibrillation and Cytotoxicity. ACS Chem Neurosci. 2018;9:230-240 pubmed publisher

Paleologou K, Schmid A, Rospigliosi C, Kim H, Lamberto G, Fredenburg R, et al. Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of alpha-synuclein. J Biol Chem. 2008;283:16895-905 pubmed publisher